FDA Drug Recalls

Recalls / Class II

Class IID-1373-2019

Product

Lactulose Solution, USP 10 g/15 mL, For Oral or Rectal Administration, Rx Only, 16 FL. oz. Bottle, NDC:13668-574-10, Manufactured By Bio-Pharm, Levittown, PA 19057, Manufactured for Torrent Pharma Inc., Basking Ridge, NJ 07920.

Affected lot / code info
Lot #s: 18E016; 18E029, Exp. 05/2020; 18F004; 18F005; 18F039, Exp. 06/2020; 18G010; 18G017, Exp. 07/2020; 18H019, Exp. 08/2020; 18M008, Exp. 12/2020; 19A005, Exp. 01/2021; 19B010, Exp. 02/2021.

Why it was recalled

cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Recalling firm

Firm
Torrent Pharma Inc
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
2091 Hartel Ave, N/A, Levittown, Pennsylvania 19057-4506

Distribution

Quantity
153.540 bottles
Distribution pattern
Product was distributed to 9 distributors, direct accounts and relabelers who may have further distributed the product throughout the United States.

Timeline

Recall initiated
2019-05-21
FDA classified
2019-06-13
Posted by FDA
2019-06-19
Terminated
2020-10-06
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1373-2019. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls